Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Monatshefte für Chemie, 2009-10, Vol.140 (10), p.1221-1227
Ort / Verlag
Vienna: Springer Vienna
Erscheinungsjahr
2009
Link zum Volltext
Quelle
SpringerNature Journals
Beschreibungen/Notizen
The synthesis of [1-
15
N,2-
13
C]-difloxacin, an arylfluoroquinolone antibacterial agent, is reported. As a crucial initial step, the starting materials ethyl 2,4,5-trifluorobenzoylacetate, [formyl-
13
C]-triethyl orthoformate, and [
15
N]-4-fluoroaniline were reacted to ethyl [
15
N,3-
13
C]-3-(4-fluoroanilino)-2-(2,4,5-trifluorobenzoyl)acrylate. After cyclization and ester cleavage, the resulting intermediate was reacted with 1-methylpiperazine to [1-
15
N,2-
13
C]-1-(4-fluorophenyl)-6-fluoro-7-(4-methyl-1-piperazinyl)-1,4-dihydro-4-oxoquinoline-3-carboxylate, i.e., [1-
15
N,2-
13
C]-difloxacin. The overall yield was 62% based on the non-labeled and 43% based on the labeled starting materials (both used in 1.4 molar excess). The product was identified by
1
H-,
13
C-, and
15
N-NMR spectroscopy and by cochromatography (TLC, HPLC) with an authentic reference; its purity (HPLC) was above 98%. Prior to synthesis of [1-
15
N,2-
13
C]-difloxacin, non-labeled difloxacin was synthesized in order to optimize procedures and to identify and characterize all intermediates.
Graphical Abstract